These cases, which have occurred in 33 states and one jurisdiction, include some cases that are still under investigation by state health officials.
The CDC, FDA and state health departments say they're working together to figure out which products might have been used and to facilitate laboratory testing.
The CDC and various state health departments have reported widespread use of products containing THC, or tetrahydrocannabinol, the psychoactive substance in cannabis.
The chemical is now "a key focus" of the department's investigation into the illnesses.
According to health officials, patients have experienced symptoms including difficulty breathing and chest pain before being hospitalized.